Discussion of new data from the ADAGIO trial for the treatment of Parkinson's disease, and a Canadian cohort study assessing risk factors for multiple sclerosis in children.

Highlights from the April issue with a focus on aneurysmal subarachnoid haemorrhage.

Highlights from the March issue with a focus on neurodegenerative disease.

Prozac and motor function after stroke, and the effect of rapid hypothermia after brain injury.

January highlights, including discussion of research from the TRACK-HD study for Huntington's disease.

Discussion of the RE-LY trial subgroup for the secondary prevention of stroke, and phase 2 results of gene therapy for Parkinson's disease.

October issue highlights, including cilostazol compared with aspirin for secondary stroke prevention.

September issue highlights, including the effects of a longer treatment window with alteplase after stroke, and discussion of a Review about ataxia.

The use of blood-pressure-lowering therapy after stroke, limbic encephalitis, and discussion of Huntington's disease prevalence.

July highlights, including ultrasound to detect asymptomatic carotid stenosis in stroke prevention.